{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:18:18Z","timestamp":1783570698413,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04453-w","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T13:34:17Z","timestamp":1782135257000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Study of phosphorylated ribosomal protein S6 (pS6) in the clinical outcomes of patients undergoing hepatectomy for metastatic colorectal cancer"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9477-024X","authenticated-orcid":false,"given":"Rafaella Henriques Cavalcanti","family":"Torres de Melo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1513-9027","authenticated-orcid":false,"given":"Paulo Goberlianio","family":"de Barros Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6455-916X","authenticated-orcid":false,"given":"Heladio Feitosa e Castro","family":"Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayane Cardoso de Souza","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ricardo de Moura","family":"Torres de Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Julia Barbosa","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1692-086X","authenticated-orcid":false,"given":"Concei\u00e7\u00e3o Aparecida","family":"Dornelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6610-5660","authenticated-orcid":false,"given":"Carlos Gustavo","family":"Hirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"issue":"6","key":"4453_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of worldwide incidence and mortality for 36 cancer types in 185 countries. Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"Cancer J Clin"},{"key":"4453_CR2","unstructured":"Santos ACA et al. Colon Cancer. In: Brazilian Society of Surgical Oncology, editors. Brazilian Treatise on Surgical Oncology. 1st edition. Rio de Janeiro: Rubio; 2022. pp. 428\u2013431."},{"key":"4453_CR3","unstructured":"Veo CA et al. Rectal Cancer. In: Brazilian Society of Surgical Oncology, editors. Brazilian Treatise on Surgical Oncology. 1st edition. Rio de Janeiro: Rubio; 2022. pp. 432\u2013435."},{"issue":"2","key":"4453_CR4","first-page":"653","volume":"30","author":"M Zacharakis","year":"2010","unstructured":"Zacharakis M, Papadopoulos C, Charalampopoulos A, et al. Predictors of survival in stage IV metastatic colorectal cancer. Anticancer Res. 2010;30(2):653\u201360.","journal-title":"Anticancer Res"},{"issue":"2","key":"4453_CR5","first-page":"31","volume":"31","author":"DL Worthley","year":"2010","unstructured":"Worthley DL, Leggett BA. Colorectal cancer: molecular features and clinical opportunities. Clin Biochem Rev. 2010;31(2):31\u20139.","journal-title":"Clin Biochem Rev"},{"issue":"5","key":"4453_CR6","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","volume":"61","author":"ER Fearon","year":"1990","unstructured":"Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759\u201367.","journal-title":"Cell"},{"issue":"3","key":"4453_CR7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1590\/S0101-98802008000300017","volume":"28","author":"MSL Pinho","year":"2008","unstructured":"Pinho MSL. Molecular Biology of Colorectal Cancer: A Silent Revolution in Progress. Rev Bras Coloproctol. 2008;28(3):363\u20138.","journal-title":"Rev Bras Coloproctol"},{"key":"4453_CR8","doi-asserted-by":"publisher","first-page":"104018","DOI":"10.1016\/j.critrevonc.2023.104018","volume":"186","author":"A Ottaiano","year":"2023","unstructured":"Ottaiano A, Catalano A, Deidda G, et al. The prognostic role of p53 mutations in metastatic colorectal cancer: a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2023;186:104018.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"4453_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1200\/JCO.20.02088","volume":"39","author":"J Tabernero","year":"2021","unstructured":"Tabernero J, Labianca R, Roth A, et al. Encorafenib plus cetuximab as a new standard of care for previously treated BRAF V600E-mutant metastatic colorectal cancer: Updated survival results and subgroup analyses from the BEACON study. J Clin Oncol. 2021;39(4):273\u201384.","journal-title":"J Clin Oncol"},{"issue":"4","key":"4453_CR10","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1053\/j.gastro.2005.07.025","volume":"129","author":"A Sato","year":"2005","unstructured":"Sato A, Matsuzaki H, Nakagawa M, et al. \u03b2 -Catenin interacts with the product of the FUS proto-oncogene and regulates pre-mRNA splicing. Gastroenterology. 2005;129(4):1225\u201336.","journal-title":"Gastroenterology"},{"issue":"4","key":"4453_CR11","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","volume":"170","author":"DA Fruman","year":"2017","unstructured":"Fruman DA, Chiu H, Hopkins BD, et al. The PI3K pathway in human disease. Cell. 2017;170(4):605\u201335.","journal-title":"Cell"},{"issue":"1","key":"4453_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/ijms23010048","volume":"23","author":"YW Yi","year":"2021","unstructured":"Yi YW, Kim KJ, Lee SK, et al. Ribosomal protein S6: a potential therapeutic target against cancer? Int J Mol Sci. 2021;23(1):48.","journal-title":"Int J Mol Sci"},{"key":"4453_CR13","doi-asserted-by":"publisher","first-page":"1028519","DOI":"10.3389\/fcell.2023.1028519","volume":"11","author":"N Esfahanian","year":"2023","unstructured":"Esfahanian N, Zeynizadeh M, Hamedifar H, et al. Mortalin: protein partners, biological impacts, pathological functions and therapeutic opportunities. Front Cell Dev Biol. 2023;11:1028519.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"4453_CR14","first-page":"23592","volume":"14","author":"S Kaur","year":"2022","unstructured":"Kaur S, Shams N, Zaidi SH, et al. Human epidermal growth factor receptor 2 (HER2) expression in colorectal carcinoma: a potential area of focus for future diagnostics. Cureus. 2022;14(3):23592.","journal-title":"Cureus"},{"key":"4453_CR15","doi-asserted-by":"publisher","first-page":"597497","DOI":"10.1155\/2012\/597497","volume":"2012","author":"R Kanthan","year":"2012","unstructured":"Kanthan R, Senger JL, Kanthan SC. Molecular events in primary and metastatic colorectal carcinoma: a review. Pathol Res Int. 2012;2012:597497.","journal-title":"Pathol Res Int"},{"key":"4453_CR16","unstructured":"Vaz da Silva DG et al. Management of Liver Metastases of Colorectal Origin. In: Brazilian Society of Surgical Oncology, editors. Brazilian Treatise on Surgical Oncology. 1st edition. Rio de Janeiro: Rubio; 2022. pp. 466\u2013468."},{"issue":"1","key":"4453_CR17","first-page":"31","volume":"30","author":"ML Zanotelli","year":"2010","unstructured":"Zanotelli ML, Feier F, Nunes AG. Liver Surgery: 9 Years of Experience at the Hospital de Cl\u00ednicas de Porto Alegre. Rev Hosp Cl\u00ednica Porto Alegre. 2010;30(1):31\u20135.","journal-title":"Rev Hosp Cl\u00ednica Porto Alegre"},{"issue":"23","key":"4453_CR18","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1002\/cncr.32163","volume":"125","author":"S Piawah","year":"2019","unstructured":"Piawah S, Venook AP. Targeted therapy for metastatic colorectal cancer: a review of current methods of targeted molecular therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer. Cancer. 2019;125(23):4139\u201347.","journal-title":"Cancer"},{"issue":"8","key":"4453_CR19","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41374-021-00590-w","volume":"101","author":"Y Hirashita","year":"2021","unstructured":"Hirashita Y, Miyatake Y, Hayashi S, et al. Early response in S6 ribosomal protein phosphorylation is associated with trametinib sensitivity in colorectal cancer cells. Lab Investig. 2021;101(8):1036\u201347.","journal-title":"Lab Investig"},{"issue":"9","key":"4453_CR20","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3390\/life12091403","volume":"12","author":"M Ivanova","year":"2022","unstructured":"Ivanova M, Markova G, Gramatikoff K, et al. HER2 in metastatic colorectal cancer: pathology, somatic changes and perspectives for new therapeutic regimens. Life. 2022;12(9):1403.","journal-title":"Life"},{"issue":"4","key":"4453_CR21","first-page":"736","volume":"13","author":"DC Malta","year":"2010","unstructured":"Malta DC, Stopa SR, Szwarcwald CL, et al. The STROBE initiative and the strengthening of research in observational epidemiology: a review. Rev Bras Epidemiol. 2010;13(4):736\u201343.","journal-title":"Rev Bras Epidemiol"},{"issue":"1","key":"4453_CR22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.hpb.2016.10.005","volume":"19","author":"C Sturesson","year":"2016","unstructured":"Sturesson C, et al. Initial hepatic strategy for synchronous colorectal liver metastases: an intention-to-treat analysis. HPB (Oxford). 2016;19(1):52\u20138.","journal-title":"HPB (Oxford)"},{"issue":"7","key":"4453_CR23","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1007\/s00423-022-02666-7","volume":"407","author":"Y Takamizawa","year":"2022","unstructured":"Takamizawa Y, Takahashi T, Ikeda S, et al. Prognostic impact of conversion hepatectomy for initially unresectable colorectal liver metastasis. Langenbecks Arch Surg. 2022;407(7):2893\u2013903.","journal-title":"Langenbecks Arch Surg"},{"issue":"3","key":"4453_CR24","first-page":"603","volume":"10","author":"M Manzoni","year":"2020","unstructured":"Manzoni M, Azzaro M, Pagliuca M, et al. Are Wnt\/\u03b2-Catenin and PI3K\/AKT\/mTORC1 distinct pathways in colorectal cancer? Cell Mol Gastroenterol Hepatol. 2020;10(3):603\u20135.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"2","key":"4453_CR25","first-page":"331","volume":"17","author":"M Wiesweg","year":"2018","unstructured":"Wiesweg M, Boumber Y, Ghanem S, et al. Phosphorylation of ribosomal protein kinase p70 S6 \u03b2 -1 is an independent prognostic parameter in metastatic colorectal cancer. Clin Colorectal Cancer. 2018;17(2):331\u201352.","journal-title":"Clin Colorectal Cancer"},{"key":"4453_CR26","doi-asserted-by":"publisher","unstructured":"Ding P et al. Multimodal digital biopsy for preoperative prediction of occult peritoneal metastasis in gastric cancer. npj Digit Med. 2026. https:\/\/doi.org\/10.1038\/s41746-025-02268-9. PMID: 41588105.","DOI":"10.1038\/s41746-025-02268-9"},{"key":"4453_CR27","doi-asserted-by":"publisher","unstructured":"Ding P, Yang J, Guo H et al. Multimodal Artificial Intelligence-Based Virtual Biopsy for Diagnosing Abdominal Lavage Cytology-Positive Gastric Cancer. Adv Sci (Weinh). 2025;12:e2411490. https:\/\/doi.org\/10.1002\/advs.202411490. PMID: 39985379.","DOI":"10.1002\/advs.202411490"},{"key":"4453_CR28","doi-asserted-by":"publisher","unstructured":"Ding P et al. Radiomics-based ensemble model predicts postoperative recurrence of gastric cancer. BMC Med. 2025;23:656. https:\/\/doi.org\/10.1186\/s12916-025-04393-4. PMID: 41291636.","DOI":"10.1186\/s12916-025-04393-4"},{"key":"4453_CR29","doi-asserted-by":"publisher","unstructured":"Ding P, Yang J, Chen S et al. Interpretable Multimodal Fusion Model Enhances Postoperative Recurrence Prediction in Gastric Cancer. Adv Sci (Weinh). 2025;12:e2508190. https:\/\/doi.org\/10.1002\/advs.202508190. PMID: 40944934.","DOI":"10.1002\/advs.202508190"},{"key":"4453_CR30","doi-asserted-by":"publisher","unstructured":"Ding P et al. A deep learning-based digital biopsy for predicting early recurrence in gastric cancer. Nat Commun. 2026. https:\/\/doi.org\/10.1038\/s41467-026-71347-6. PMID: 41986314.","DOI":"10.1038\/s41467-026-71347-6"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04453-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04453-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04453-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:05:11Z","timestamp":1783569911000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04453-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4453"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04453-w","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"3 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Hospital Haroldo Jua\u00e7aba \/ Instituto do C\u00e2ncer do Cear\u00e1 (CAAE: 67319223.0.0000.5528; Ethics Committee Opinion No. 6.989.739, approved on August 7, 2024). All procedures adhered to Brazilian ethical guidelines for research involving human beings (Resolution CNS 466\/12) and to the principles of the Declaration of Helsinki and the Nuremberg Code.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"282"}}